Drugsoft    drug data and web services

Hematox

Hematox®, a bibliographical databank based on drug-induced blood disorders, was created in 1983 by Michel BIOUR (MD, PhD).

This database has been monthly updated in accordance with other bibliographical databases such as Embase® (Elsevier), Medline® or X-Reactions® (Adis Press) and with the analysis of the references cited in each registered article.

The author has re-evaluated all the published cases for selection and classification in accordance with criterions usually validated in hematology.

1031 drugs are registered with 14086 corresponding and available references. Anticancer drugs and immunomodulators, well known for their intrinsic hematotoxicity, are not indexed in Hematox.

This application is available for Android, for Iphone and for Ipad

1	2
Search for a drug	Get blood disorder subtypes
	3
Hematox® is a bibliographical tool used as a support for: - evaluating the role of drug(s) as a cause of blood disorder, - safety, by avoiding to prescribe any drug known to cause any type of blood disorder in a patient at risk, - pharmacoepidemiological studies especially for case/no-case type. This specific type of database requires anyway a few safety practices. Actually, three precautions have to be taken by the readers prior using our database: a) a drug which is known for its hematotoxicity is not always the only cause of a blood disorder observed in a patient; b) and vice versa, the blood disorder may come from another drug which is not registered in our list; c) the hematotoxic potential of each drug could be evaluated through the number of references in the index. Nevertheless, this method is strongly inadvisable for drugs marketed in only one country. Antineoplastic agents and immunomosuppressants, known for their hematotoxicity, are not included in this file. The figures indicated at each item drug-related-type of blood disorder is relevant to the number of bibliographical references registered in the database index.